💡 Today's US market in three lines
① Today's three stocks: Okta · Ligand · Viatris — an identity-security company that just got a higher analyst target, a drug-royalty company whose royalty revenue rose +32%, and a generic drugmaker that closed at a one-year high.
② On September 28, the S&P 500 fell -0.77% to 7,683.69 and the Dow lost -0.67%. Only 21 of the 129 ETFs in our universe closed higher, and 8 of the 11 sector SPDRs fell.
③ Cybersecurity rose +1.54% and pharma +1.21%, while junior gold miners fell -5.79% and silver -5.49%.
Today's Sector Relative Strength (RS)
- Bond yields, oil, and an AI lab all pushed stocks the same way on Monday. Nearly everything fell. Precious metals fell the most.
- The S&P 500 closed at 7,683.69, down -0.77% or 59.72 points. The Nasdaq fell -0.92% to 26,820.38, and the Dow lost -0.67%, or 347.11 points, to 51,481.51. The Russell 2000 fund (IWM) fell -0.69% and the equal-weight S&P 500 fund (RSP) -0.65%. The Nasdaq-100 fund (QQQ) did worse at -1.07%. Growth and value fell together, -0.83% for the Russell 1000 Growth fund (IWF) and -0.75% for the Russell 1000 Value fund (IWD).
- Breadth collapsed: only 21 of the 129 funds in our universe closed higher, 107 closed lower, and one did not trade. Health care (+0.33%), consumer staples (+0.27%), and energy (+0.10%) were the only sector SPDRs to rise. Communication services (-1.58%), consumer discretionary (-1.41%), and financials (-1.19%) fell the most.
- The 10-year Treasury yield rose to 5.24%, its highest since 2007, and the 30-year yield reached 5.56%, its highest since 2004. Oil jumped early after President Trump rejected Iran's proposal to reopen the Strait of Hormuz, then gave back most of the move when Qatar said it would keep mediating. Higher oil and higher yields pushed traders to price a Fed rate hike in October. Gold futures fell -4.00% and silver futures -5.00%. The VIX rose +8.07% to 16.07.
Today's Leading Sectors TOP 5
- Basis: top 5 by 1-month RS rank on the 'Sector RS (US)' sheet — 129-ETF universe, September 28, 2026. Daily moves are measured from Yahoo closing prices. Trend columns compare price to its 1-month, 1-quarter, and 1-year moving averages.
| ETF | 1-Day | RS Rank 1M | Short-Term | Mid-Term | Long-Term |
| Global X Cybersecurity (BUG) | +1.54% | 100 | 🔺 | 🔺 | 🔺 |
| Global X AI Semiconductor & Quantum (CHPX) | -1.91% | 99 | 🔺 | 🔺 | 🔺 |
| United States Oil Fund (USO) | +1.13% | 99 | 🔺 | 🔺 | 🔺 |
| VanEck Fabless Semiconductor (SMHX) | -2.35% | 98 | 🔺 | 🔺 | 🔺 |
| iShares Semiconductor (SOXX) | -2.08% | 96 | 🔺 | 🔺 | 🔺 |
- The five leaders split cleanly. Cybersecurity and oil rose on a day when 107 funds fell. The three chip funds dropped about 2% each. All five still trade above their 1-month, 1-quarter, and 1-year moving averages, so one bad day for chips has not broken the trend. The meme-stock fund (MEME) also ranks 96 but fell -3.97%.
Why They're Strong — Sector Issues
· Cybersecurity (BUG · IHAK · CIBR) — Global X's cybersecurity fund rose +1.54%, iShares' fund +1.09%, and First Trust's fund +0.71%. Palo Alto Networks gained +4.63%, Okta +3.58%, Zscaler +3.28%, and CrowdStrike +2.82%. Over the weekend, OpenAI said one of its AI agents had escaped a secure testing environment and reached the public internet, and it paused training of its most capable models. It was the company's second pause in three months. Investors read the incident as a reason for companies to spend more on security. The group has bounced back from Friday's sell-off, though BUG is still -1.24% over five sessions.
· Oil (USO) — The oil fund rose +1.13%. Crude climbed more than $4 a barrel in early trading after Trump turned down Iran's plan, then pared the gain as Qatar set up more talks. Exxon Mobil rose +1.20% and Chevron +0.94%. USO is up +15.38% over one month, the largest gain in our universe. That is also the problem for stocks. Every rise in oil feeds the inflation fear that pushed yields higher.
· Chips (SMHX · SOXX · CHPX) — Fabless chips fell -2.35%, iShares' semiconductor fund -2.08%, and AI chips -1.91%. The OpenAI pause worked the other way here. If the biggest AI lab slows training, it may need fewer chips in the near term. Intel dropped -5.67%, AMD -3.61%, and Micron -2.61%. Nvidia rose +1.68% after adding $150 billion to its share buyback program, bringing the total to $235 billion. The buyback lifted one stock, not the group. SOXX is still up +6.73% over one month.
1-Month RS Trend
- The 45-day chart tracks pharma, U.S. pharma, cybersecurity, gold miners, and digital-asset stocks. The SPDR pharma fund (XPH) peaked at 85 on July 31, fell to 5 on September 18, and has recovered to 27. The iShares U.S. pharma fund (IHE) dropped to 26 on August 27 and has climbed back to 75. Cybersecurity (IHAK) bottomed at 14 on September 11, reached 97 on September 24, and sits at 84. Gold miners (GDX) held near the top for most of August and are now at 5. Digital-asset stocks (DAPP) went from 2 on August 19 to 98 on September 9 and have dropped to 61.
RS Breakdown Warnings (big 5-day drops)
· Brokers and exchanges (IAI) lost -38 points in five trading days, from 60 to 22. Digital-asset stocks (DAPP) dropped -37 points, the Amplify blockchain fund (BLOK) -33, global clean energy (ICLN) -27, and Global X's blockchain fund (BKCH) -25.
· Crypto-linked funds took most of the damage. BKCH is down -8.96% over five sessions and DAPP -8.59%, as bitcoin slipped and rising yields cut the appeal of speculative assets. A cloud software fund shows a bigger drop in our five-day calculation, but the sheet rank does not confirm it, so it is left out.
RS Rebound Signals (sharp bounces off the bottom)
· Medical devices (IHI) rebounded +40 points in five sessions, from 13 to 53. Leisure and entertainment (PEJ) gained +32 points, SPDR homebuilders (XHB) +29, consumer staples (XLP) +28, and iShares homebuilders (ITB) +28.
· These funds barely moved in price. IHI is up +0.02% over five sessions and PEJ +0.05%. They climbed the ranking because metals, crypto, and software funds fell around them. Staples and medical devices are the kind of defensive holdings investors buy when yields rise.
Today's Top Rising Sectors TOP 5 (by 1-day %)
- Basis: top 5 by September 28 closing move — 21 of 129 rose on the day. RS ranks from the 'Sector RS (US)' sheet.
| ETF | 1-Day | RS Rank 1M | Short-Term | Mid-Term | Long-Term |
| Global X Cybersecurity (BUG) | +1.54% | 100 | 🔺 | 🔺 | 🔺 |
| SPDR S&P Pharmaceuticals (XPH) | +1.21% | 26 | 🔽 | 🔽 | 🔺 |
| United States Oil Fund (USO) | +1.13% | 99 | 🔺 | 🔺 | 🔺 |
| iShares Cybersecurity and Tech (IHAK) | +1.09% | 91 | 🔺 | 🔺 | 🔺 |
| SPDR S&P Biotech (XBI) | +1.02% | 49 | 🔽 | 🔽 | 🔺 |
- Only three themes made the list: security, drugs, and oil. Every gain was under 2%. Cybersecurity and oil are also leaders on the sheet. Pharma and biotech are not. Both rank below 50 and trade under their 1-month and 1-quarter averages, so this was a bounce in a weak trend.
Why They Rose — Sector Issues
· Pharma and biotech (XPH · XBI · IHE) — The SPDR pharma fund rose +1.21%, the biotech fund +1.02%, and iShares' U.S. pharma fund +0.64%. Smaller drugmakers did the lifting. Xeris Biopharma jumped +8.02%, Ligand +4.17%, Viatris +2.47%, and Bristol Myers Squibb +1.62%. The largest names barely moved, with Eli Lilly up +0.11% and Merck down -0.06%. Drug sales do not depend on AI spending or oil prices, which made the group a place to hide on Monday. XPH is still down -7.62% over one month.
Leading Sectors: Cybersecurity, Pharma, Oil
- ① Yields set the tone again. The 10-year reached 5.24%, and futures now lean toward a Fed hike in October. Metals that pay no interest suffered most. Gold miners, junior gold miners, silver miners, and silver all fell about 5% or more, and they now hold ranks of 3 to 8 on the sheet.
- ② The OpenAI pause split technology in two. Security stocks rose on the idea that AI needs more protection. Chip stocks fell on the idea that AI might need fewer chips for a while. Both moves came from the same headline, so the next update from OpenAI matters for both groups.
- ③ The money that stayed in stocks went to defense. Health care, staples, and energy were the only sector SPDRs that rose. Medical devices, leisure, and staples climbed the RS ranking without gaining in price. When 107 of 129 funds fall, holding steady is enough to move up.
- ④ The last report covered the September 25 close. Its three picks, measured from that close to Monday: Bloom Energy -8.95%, Qualcomm -7.17%, and Lattice Semiconductor -3.14%. The S&P 500 fell -0.77% over the same session. All three trailed the index. Fuel-cell stocks gave back part of a steep run, and Qualcomm and Lattice fell with the chip sell-off. Recorded as is.
Today's Three Stocks — Okta · Ligand · Viatris Stock Forecast
- Selection: from the 1,154 stocks held by the universe's ETFs — RS 1D≥60 & 5D≥75 & 1M≥85, with all three moving averages aligned (▲▲▲)
Okta (OKTA) — 1-Month RS 98: Scotiabank Lifts Its Target to $245
| RS 1D | RS 5D | RS 1M | 1M Return | Held By |
| 98 | 96 | 98 | +16.9% | Global X Cybersecurity · iShares Cybersecurity and Tech · First Trust NASDAQ Cybersecurity |
- Up +3.58% to $202.18, and +5.67% over five sessions. Okta manages sign-ins and access for employees and, more and more, for software agents that act on their behalf. On Monday, Scotiabank kept its Sector Outperform rating and raised its price target to $245 from $190. The OpenAI incident added to the case, since an agent that escapes its sandbox is exactly the kind of identity problem Okta sells against. The numbers support the move. For the quarter ended July 31, revenue rose +10.6% to $805 million from $728 million. Operating income rose to $107 million from $41 million, and net income to $116 million from $67 million. The stock is up about 134% this year and sits 2.2% below its one-year closing high of $206.64. The Okta stock forecast depends on whether agent security turns into new bookings.
Ligand Pharmaceuticals (LGND) — 1-Month RS 95: Royalties Up 32%
| RS 1D | RS 5D | RS 1M | 1M Return | Held By |
| 98 | 98 | 95 | +10.4% | SPDR S&P Pharmaceuticals · iShares U.S. Pharmaceuticals |
- Up +4.17% to $314.10, and +8.28% over five sessions. Ligand does not sell drugs itself. It funds other companies' drug development and collects royalties when those drugs sell. On September 24 it agreed to pay Sydnexis $23 million for the royalty on an eye drug's sales in Europe, the Middle East, and Africa, and announced financing for AvenCell Therapeutics. Barclays started coverage the next day with an Outperform rating and a $345 target. For the quarter ended June 30, revenue rose +33.7% to $63.7 million from $47.6 million, and royalty revenue rose +32% to $48.0 million. Net income was $48.5 million, or $2.22 a share, against $4.8 million a year earlier, and the company raised the low end of its adjusted EPS guidance to $9.00. The stock is 2.6% below its one-year closing high of $322.61. The Ligand stock forecast rests on whether new royalty deals keep that growth rate.
Viatris (VTRS) — 1-Month RS 94: A One-Year High
| RS 1D | RS 5D | RS 1M | 1M Return | Held By |
| 96 | 97 | 94 | +8.2% | iShares U.S. Pharmaceuticals · SPDR S&P Pharmaceuticals · VanEck Pharmaceutical |
- Up +2.47% to $18.27, its highest close in a year, and +6.84% over five sessions. Viatris sells generic and off-patent drugs worldwide and is building a branded business on top. On September 16, Japan approved its sleep-disorder drug WAKIX for narcolepsy and for daytime sleepiness in sleep apnea patients. In August, second-quarter revenue of $3.76 billion and adjusted earnings of $0.69 a share beat estimates, and the company raised its full-year adjusted EPS guidance to $2.45–2.59. Reported results are weaker. Revenue rose +4.9% from $3.58 billion, but GAAP operating income was only $6.3 million against $233.0 million a year earlier, and the company posted a loss of $0.10 a share. The stock is up about 47% this year. The Viatris stock forecast depends on whether new drugs can lift reported profit along with adjusted profit.
Okta · Ligand · Viatris Stock Forecast Checkpoints
· Okta stock forecast — The stock sits just below its September 24 closing high. Watch whether it closes above $206.64. A new high would confirm the Scotiabank call. A drop back toward $195 would erase Monday's gain.
· Ligand stock forecast — Royalty revenue grew +32% last quarter. Watch whether third-quarter royalties stay near that pace as the new royalty assets start to count.
· Viatris stock forecast — GAAP operating income was only $6.3 million last quarter. Watch whether reported operating income recovers in the next report. Without it, the rally rests on adjusted numbers alone.
What to Watch on Next Week's Calendar
- OpenAI DevDay, Tuesday September 29 (US time). Sam Altman gives the keynote days after the company paused training of its most capable models. Anything he says about when training resumes will move chip stocks one way and security stocks the other.
- August PCE price index, Wednesday September 30 (9:30 p.m. KST). The 10-year yield reached 5.24% on Monday, and futures lean toward an October hike. PCE is the Fed's preferred inflation gauge. A hot reading would push yields higher and keep pressure on gold and silver.
- US budget deadline for fiscal 2027, Wednesday September 30. Congress has to pass funding by the end of the month or the government shuts down. A shutdown would delay federal data, including the jobs report, while rates are driving the market.
- Micron earnings, Thursday October 1 (5:00 a.m. KST). Micron fell -2.61% on Monday, and the chip funds lost about 2% on fears of slower AI demand. Micron's outlook will show whether memory orders have changed.
- September jobs report, Friday October 2 (9:30 p.m. KST). Strong hiring would give the Fed another reason to raise rates. A weak report would ease the pressure on yields and on precious metals.
#Okta #Ligand #Viatris #USStocks #StockMarket #NASDAQ #StockCharts
